Soluble guanylyl cyclase activators increase the expression of tolerance to morphine analgesic effect

Bratislava Medical Journal

Volumn 115, Issue 6, 2014, Pages 334-339

  Durmus, N ^a   Bagcivan, I ^b   Ozdemir, E ^b   Altun, A ^b   Gursoy, S ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Analgesia; Morphine tolerance; Soluble guanylyl cyclase

Indexed keywords

1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CELL RECEPTOR; DRUG DERIVATIVE; ENZYME ACTIVATOR; ENZYME INHIBITOR; GUANYLATE CYCLASE; LINSIDOMINE; MOLSIDOMINE; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; NARCOTIC ANALGESIC AGENT; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; OXADIAZOLE DERIVATIVE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; QUINOXALINE DERIVATIVE; SOLUBLE GUANYLYL CYCLASE;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG TOLERANCE; MALE; METABOLISM; RAT; RESTRICTION MAPPING; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; ENZYME ACTIVATORS; ENZYME INHIBITORS; GUANYLATE CYCLASE; MALE; MOLSIDOMINE; MORPHINE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; OXADIAZOLES; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESTRICTION MAPPING; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 84906555807     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2014_066     Document Type: Article

References (29)

1. Ossipov MH, Lai J, Vanderah TW, Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003; 73: 783-800.
2. Ossipov, MH, Lai J, King T, Vanderah TW, Malan TP Jr, Hruby VJ, Porreca F. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004; 61: 126-148.
3. McNally GP. Pain facilitatory circuits in the mammalian central nervous system: their behavioral signifi cance and role in morphine analgesic tolerance. Neurosci Biobehav 1999; 23: 1059-1078.
4. Law PY, Loh HH, Wei LN. Insights into the receptor transcription andsignaling: implications in opioid tolerance and dependence. Neuropharmacology 2004; 47: 300-311.
5. Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem 2004; 73: 953-990.
6. Bredt D. S. and Snyder S. H. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8: 3-11.
7. Derbyshire ER, Marletta MA. Structure and Regulation of Soluble Guanylate Cyclase. Annu Rev Biochem 2012; 81: 533-559.
8. Ignarro LJ, Wood KS, Wolin MS. Activation of purifi ed soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad ScL USA 1982; 79: 2870-2873.
9. Sousa AM, Prado WA. The dual effect of a nitric oxide donor in nociception. Brain Res 2001; 897: 9-19.
10. Li X, Clark JD. Spinal cord nitric oxide synthase and heme oxygenase limit morphine induced analgesia. Mol Brain Res 2001; 95: 96-102.
11. Cechova S, Pajewski TN. The soluble guanylyl cyclase inhibitor ODQ, 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, dose-dependently reduces the threshold for isofl urane anesthesia in rats. Anesth Analg 2004; 99: 752-757.
12. Joharchi K, Jorjani M. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats. Eur J Pharmacol 2007; 570: 66-71.
13. Morgan MM, Bobeck EN, Ingram SL. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res 2009; 1295: 59-66.
14. Nayebi AR, Rezazadeh H, Parsal Y. Effect of fl uoxetine on tolerance to the analgesic effect of morphine in mice with skin cancer. Pharmal Rep 2009; 61: 453-458.
15. Heinzen EL, Pollack GM. The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice. Biochem Pharmacol 2004; 67: 735-741.
16. Koch T, Hollt V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 2008; 117: 199-206.
17. Liu J, Anand KJS. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev 2001; 38: 1-19.
18. Taylor DA, Fleming WW. Unifying perspectives in the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 2001; 297: 11-18.
19. Bhargava HN. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self administrative behavior. Pharmacol Rev 1994; 46: 293-324.
20. Dambisya YM, Lee TL. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 1996; 117: 914-918.
21. Watanabe C, Okuda K, Sakurada C, Ando R, Sakurada T, Sakurada S. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats. Brain Res 2003; 990: 77-86.
22. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993; 54: 291-300.
23. Machelska H, Labuz D, Przewlocki R, Przewlocki B. Inhibition of nitric oxide synthase enhances antinociception mediated by Mu, Delta and Kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 1997; 282: 977-984.
24. Pasternak GW, Kolesnikov YA, Babey AM. Perspectives on the Nmethyl- D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 1995; 13: 309-313.
25. Ulugol A, Aslantas A, Karadag HC, Bulbul ED, Tuncer A, Dokmeci I. The effect of combined systemic administration of morphine and L-name, a nitric oxide synthase inhibitor, on behavioral signs of neuropathic pain in rats. Neurosci Res Commun 2002; 30: 143-153.
26. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. New Engl J Med 1993; 329: 2002-2012.
27. Romero A, Hernandez L, Garcia-Nogales P, Puig MM. Deletion of the inducible nitric oxide synthase gene reduces peripheral morphine tolerance in a mouse model of chronic infl ammation. Fund Cli Pharm 2010; 24: 317-323.
28. Xu JY, Hill KP, Bidlack JM. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J Pharmacol Exp Therap 1998; 284: 196-201.
29. Hess DT, Lin LH, Freeman JA,Norden J J. Modifi cation of cysteine residues with Go and other neuronal proteins by exposure to nitric oxide. Neuropharmacology 1994; 33: 1283-1292.